<DOC>
	<DOCNO>NCT00167219</DOCNO>
	<brief_summary>The investigator hypothesize long-term disease-free survival ( DFS ) patient JMML achieve treatment busulfan ( BU ) , cyclophosphamide ( CY ) melphalan ( L-PAM ) follow hematopoietic cell transplantation ( HCT ) .</brief_summary>
	<brief_title>Stem Cell Transplant Juvenile Myelomonocytic Leukemia ( JMML )</brief_title>
	<detailed_description>Prior transplantation , subject receive BUSULFAN via central venous line , six time day four day , CYCLOPHOSPHAMIDE via central venous line day two day , MELPHALAN via central venous line one day . Busulfan , cyclophosphamide , melphalan give destroy subject 's leukemia . As well , drug destroy subject 's immune system help ensure new bone marrow take grows transplantation . On day transplantation , bone marrow umbilical cord blood donor arrive bone marrow transplant unit transfuse via venous line . These new cell replace subject 's bone marrow .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Acute</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Chronic</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Juvenile</mesh_term>
	<criteria>Patients must diagnosis JMML fulfill minimal criterion ( International diagnostic criterion JMML ) : Leukocytosis ( &gt; 13,000 ) absolute monocytosis ( &gt; 1,000 ) The presence immature myeloid cell peripheral blood Less 30 % marrow blast Absence ( 9:22 ) BCRABL transcript Adequate major organ function include : Cardiac : ejection fraction &gt; 45 % Hepatic : clinical evidence hepatic failure ( e.g . coagulopathy , ascites ) Karnofsky performance status &gt; 70 % Lansky score &gt; 50 % Creatinine must &lt; 2 x normal age Written inform consent . Active uncontrolled infection within one week HCT .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Stem cell transplant</keyword>
	<keyword>long term survival</keyword>
	<keyword>retinoic acid</keyword>
</DOC>